Search results
Results from the WOW.Com Content Network
Bladder sphincter dyssynergia (also known as detrusor sphincter dyssynergia (DSD) (the ICS standard terminology agreed 1998) [1] and neurogenic detrusor overactivity (NDO)) is a consequence of a neurological pathology such as spinal injury [2] or multiple sclerosis [3] which disrupts central nervous system regulation of the micturition (urination) reflex resulting in dyscoordination of the ...
Bladder sphincter dyssynergia also known as detrusor sphincter dyssynergia is the decrease of detrusor (wall muscle of the bladder) pressure which causes unwanted urination. This is very common in spinal cord injuries and multiple sclerosis patients. There is a malfunction between the central nervous system, urinary sphincters, and detrusor ...
Pseudodyssynergia (or detrusor sphincter pseudodyssynergia) is an urological condition involving contraction of the male or female external sphincter during voiding. [1] Coordination between the sphincter and detrusor is thus lost. [2]
Then, use a skin soothing treatment like calamine lotion to combat the irritation, per the Cleveland Clinic. OTC anti-itch creams or ointments, along with antihistamines can relieve itchy skin and ...
Treatment depends on the type of neurogenic bladder and other medical problems. Treatment strategies include catheterization, medications, surgeries or other procedures. The goals of treatment focus on preserving the structure and function of the upper urinary tract, and on improving the quality of life for patients with neurogenic bladder. [2]
Urinary retention is a disorder treated in a hospital, and the quicker one seeks treatment, the fewer the complications. [citation needed] In the longer term, obstruction of the urinary tract may cause: [citation needed] Bladder stones; Atrophy of the detrusor muscle (atonic bladder is an extreme form) Hydronephrosis (congestion of the kidneys)
The efficacy of solifenacin to treat neurogenic detrusor overactivity (NDO) was established in two clinical trials with a total of 95 pediatric NDO participants, ages two to 17 years old. [2] The studies were designed to measure (as a primary efficacy endpoint) the maximum amount of urine the bladder could hold after 24 weeks of treatment. [2]
Dr. Smita Ramanadham, a plastic surgeon in New Jersey, added: “We see a loss of volume in the face [with weight loss], and when we lose fat in the face we see signs like the cheeks are more ...